Breaking News Instant updates and real-time market news.

ADAP

Adaptimmune

$4.86 /

+0.09 (+1.89%)

07:33
05/29/20
05/29
07:33
05/29/20
07:33

Adaptimmune presented updated data from its ADP-A2M4 Phase 1 trial at ASCO

Adaptimmune Therapeutics presented updated data from its ADP-A2M4 Phase 1 trial at the American Society for Clinical OncologyAnnual Meeting. The data demonstrate durability and responses in synovial sarcoma, supporting SPEARHEAD-1 as a potential registrational trial. The ASCO presentation also describes a new response in a patient with lung cancer, and a response in a patient with head and neck cancer.The Company also announced new responses in the SURPASS trial, confirming the potential for SPEAR T-cell therapies targeting MAGE-A4 to treat a broad range of cancers in addition to sarcoma. These data further support the rationale for two new Phase 2 trials - SPEARHEAD-2 in head and neck cancer, which will begin later this year, and a second trial in esophagogastric junction (EGJ) cancer planned for 1H 2021. A webcast of Dr. Elliot Norry, Adaptimmune's Chief Medical Officer, and Adrian Rawcliffe, Adaptimmune's Chief Executive Officer, summarizing these and other clinical data is available here: URL "I am pleased to announce that we have identified a new indication to progress into late stage development. We plan to initiate a Phase 2 trial in esophagogastric junction cancer in the first half of 2021, with our next-generation ADP-A2M4CD8 SPEAR T-cells. In addition, the ASCO data demonstrate promising durability for ADP-A2M4 in sarcoma bolstering our ambition to have our first marketed therapy in 2022," said Adrian Rawcliffe, CEO. "I'm thrilled with the responses in a broad range of tumors with our programs targeting MAGE-A4 and AFP. I am confident that we will be able to identify more indications for late stage development as more patients are treated in our trials."

  • 29

    May

ADAP Adaptimmune
$4.86 /

+0.09 (+1.89%)

04/21/20 Mizuho
Adaptimmune initiated with a Neutral at Mizuho
10/23/19
Adaptimmune management to meet with SunTrust
08/02/19
Fly Intel: Top five analyst downgrades
08/02/19 Guggenheim
Adaptimmune downgraded to Neutral on low near-term visibility at Guggenheim

TODAY'S FREE FLY STORIES

Syndicate
Level One files $100M mixed securities shelf  17:30
07/02/20
07/02
17:30
07/02/20
17:30
LEVL

Level One

$16.23 /

+ (+0.00%)

 
ShowHide Related Items >><<
LEVL Level One
$16.23 /

+ (+0.00%)

LEVL Level One
$16.23 /

+ (+0.00%)

Syndicate
Inseego files to sell $80M in senior convertible notes  17:29
07/02/20
07/02
17:29
07/02/20
17:29
INSG

Inseego

$11.37 /

-0.14 (-1.22%)

 
ShowHide Related Items >><<
INSG Inseego
$11.37 /

-0.14 (-1.22%)

INSG Inseego
$11.37 /

-0.14 (-1.22%)

06/25/20 Stifel
Inseego initiated with a Buy at Stifel
05/19/20 Cowen
Inseego price target raised to $13.50 from $12 at Cowen
04/30/20 Vertical Group
Inseego initiated with a Sell at Vertical Group
04/14/20 Canaccord
Inseego price target raised to $14 from $10 at Canaccord
INSG Inseego
$11.37 /

-0.14 (-1.22%)

INSG Inseego
$11.37 /

-0.14 (-1.22%)

INSG Inseego
$11.37 /

-0.14 (-1.22%)

Syndicate
Ekso Bionics files to sell 874K shares of common stock for holders  17:25
07/02/20
07/02
17:25
07/02/20
17:25
EKSO

Ekso Bionics

$7.35 /

+0.04 (+0.55%)

 
ShowHide Related Items >><<
EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

06/26/20 H.C. Wainwright
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright
01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

Syndicate
Adial Pharmaceuticals files to sell 2.12M shares of common stock for holders  17:24
07/02/20
07/02
17:24
07/02/20
17:24
ADIL

Adial Pharmaceuticals

$1.36 /

-0.05 (-3.55%)

 
ShowHide Related Items >><<
ADIL Adial Pharmaceuticals
$1.36 /

-0.05 (-3.55%)

ADIL Adial Pharmaceuticals
$1.36 /

-0.05 (-3.55%)

Hot Stocks
Medical Properties Trust CFO sells 220K shares of common stock » 17:13
07/02/20
07/02
17:13
07/02/20
17:13
MPW

Medical Properties Trust

$19.03 /

-0.29 (-1.50%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPW Medical Properties Trust
$19.03 /

-0.29 (-1.50%)

MPW Medical Properties Trust
$19.03 /

-0.29 (-1.50%)

04/23/20 SunTrust
SunTrust lowers price targets on select healthcare REITS
03/30/20 Mizuho
Medical Properties Trust downgraded to Neutral from Buy at Mizuho
03/30/20 Mizuho
Medical Properties Trust downgraded to Neutral from Buy at Mizuho
03/23/20 BofA
Medical Properties Trust upgraded to Buy from Neutral at BofA
MPW Medical Properties Trust
$19.03 /

-0.29 (-1.50%)

  • 06
    Nov
  • 25
    Jul
  • 16
    Jul
MPW Medical Properties Trust
$19.03 /

-0.29 (-1.50%)

General news
Treasury Market Summary » 17:10
07/02/20
07/02
17:10
07/02/20
17:10

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Cyclerion Therapeutics to host conference call » 17:05
07/02/20
07/02
17:05
07/02/20
17:05
CYCN

Cyclerion Therapeutics

$5.86 /

+0.01 (+0.17%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYCN Cyclerion Therapeutics
$5.86 /

+0.01 (+0.17%)

CYCN Cyclerion Therapeutics
$5.86 /

+0.01 (+0.17%)

02/26/20 Spin-Off Research
Cyclerion Therapeutics downgraded to Hold from Buy at Spin-Off Research
08/21/19 Spin-Off Research
Cyclerion Therapeutics upgraded to Buy from Hold at Spin-Off Research
CYCN Cyclerion Therapeutics
$5.86 /

+0.01 (+0.17%)

Syndicate
Sonim files to sell 8.23M shares of common stock for holders  17:05
07/02/20
07/02
17:05
07/02/20
17:05
SONM

Sonim

$0.82 /

+0.023 (+2.87%)

 
ShowHide Related Items >><<
SONM Sonim
$0.82 /

+0.023 (+2.87%)

SONM Sonim
$0.82 /

+0.023 (+2.87%)

03/16/20 Lake Street
Sonim price target lowered to $2 from $3 at Lake Street
10/31/19 Oppenheimer
Sonim downgraded to Perform from Outperform at Oppenheimer
10/31/19 Oppenheimer
Sonim downgraded to Perform from Outperform at Oppenheimer
09/11/19 Oppenheimer
Sonim price target lowered to $6 from $18 at Oppenheimer
SONM Sonim
$0.82 /

+0.023 (+2.87%)

  • 05
    Jun
Syndicate
CEL-SCI files to sell 613,792 shares of common stock for holders  17:04
07/02/20
07/02
17:04
07/02/20
17:04
CVM

CEL-SCI

$13.45 /

-0.9 (-6.27%)

 
ShowHide Related Items >><<
CVM CEL-SCI
$13.45 /

-0.9 (-6.27%)

CVM CEL-SCI
$13.45 /

-0.9 (-6.27%)

05/14/20 H.C. Wainwright
CEL-SCI price target raised to $23 from $18 at H.C. Wainwright
01/13/20 H.C. Wainwright
CEL-SCI initiated with a Buy at H.C. Wainwright
  • 24
    Dec
CVM CEL-SCI
$13.45 /

-0.9 (-6.27%)

CVM CEL-SCI
$13.45 /

-0.9 (-6.27%)

Hot Stocks
Anixa redirects resources to therapeutics, vaccines in high-need patients » 17:02
07/02/20
07/02
17:02
07/02/20
17:02
ANIX

Anixa Biosciences

$3.16 /

+0.19 (+6.40%)

Anixa Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANIX Anixa Biosciences
$3.16 /

+0.19 (+6.40%)

ANIX Anixa Biosciences
$3.16 /

+0.19 (+6.40%)

12/30/19 B. Riley FBR
Anixa Biosciences price target lowered to $8 from $11.25 at B. Riley FBR
Hot Stocks
Pyxis Tankers discloses continued listing notice from Nasdaq » 17:01
07/02/20
07/02
17:01
07/02/20
17:01
PXS

Pyxis Tankers

$0.79 /

+0.0299 (+3.93%)

Pyxis Tankers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PXS Pyxis Tankers
$0.79 /

+0.0299 (+3.93%)

PXS Pyxis Tankers
$0.79 /

+0.0299 (+3.93%)

10/15/19 Aegis
Pyxis Tankers initiated with a Buy at Aegis
PXS Pyxis Tankers
$0.79 /

+0.0299 (+3.93%)

Hot Stocks
Zynga to acquire Toon Blast developer Peak for $1.85B » 16:57
07/02/20
07/02
16:57
07/02/20
16:57
ZNGA

Zynga

$9.52 /

-0.24 (-2.46%)

Zynga has entered into a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

06/22/20 MKM Partners
Snap's new features impressive, says MKM Partners
06/09/20
Fly Intel: Top five analyst upgrades
06/09/20 Barclays
Barclays upgrades Zynga with Peak seen as share inflection point
06/09/20 Barclays
Zynga upgraded to Overweight from Equal Weight at Barclays
ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

ZNGA Zynga
$9.52 /

-0.24 (-2.46%)

Syndicate
Hercules Capital files to sell 16.5M shares of common stock » 16:54
07/02/20
07/02
16:54
07/02/20
16:54
HTGC

Hercules Capital

$10.41 /

+0.095 (+0.92%)

JMP Securities is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HTGC Hercules Capital
$10.41 /

+0.095 (+0.92%)

HTGC Hercules Capital
$10.41 /

+0.095 (+0.92%)

06/19/20 Janney Montgomery Scott
Hercules Capital upgraded to Buy at Janney Montgomery Scott
06/19/20 Janney Montgomery Scott
Hercules Capital upgraded to Buy from Neutral at Janney Montgomery Scott
03/31/20 Keefe Bruyette
Hercules Capital upgraded to Outperform from Market Perform at Keefe Bruyette
02/21/20 B. Riley FBR
Hercules Capital price target raised to $17 from $15 at B. Riley FBR
HTGC Hercules Capital
$10.41 /

+0.095 (+0.92%)

Periodicals
Delta issues 2,558 potential layoff notices to pilots, Bloomberg reports  16:48
07/02/20
07/02
16:48
07/02/20
16:48
DAL

Delta Air Lines

$27.71 /

+ (+0.00%)

 
ShowHide Related Items >><<
DAL Delta Air Lines
$27.71 /

+ (+0.00%)

DAL Delta Air Lines
$27.71 /

+ (+0.00%)

06/29/20 Goldman Sachs
Delta Air Lines price target raised to $38 from $33 at Goldman Sachs
06/16/20 Stifel
United loyalty deal raises odds of survival without restructuring, says Stifel
06/10/20 JPMorgan
Delta Air Lines price target lowered to $41 from $45 at JPMorgan
06/05/20 Credit Suisse
American stock reaction to demand commentary 'confounding,' says Credit Suisse
DAL Delta Air Lines
$27.71 /

+ (+0.00%)

DAL Delta Air Lines
$27.71 /

+ (+0.00%)

DAL Delta Air Lines
$27.71 /

+ (+0.00%)

DAL Delta Air Lines
$27.71 /

+ (+0.00%)

Conference/Events
Chembio Diagnostics to host business news update conference call » 16:43
07/02/20
07/02
16:43
07/02/20
16:43
CEMI

Chembio Diagnostics

$4.17 /

+0.89 (+27.13%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CEMI Chembio Diagnostics
$4.17 /

+0.89 (+27.13%)

CEMI Chembio Diagnostics
$4.17 /

+0.89 (+27.13%)

06/17/20
Fly Intel: Top five analyst downgrades
06/17/20 Craig-Hallum
Chembio Diagnostics downgraded to Hold from Buy at Craig-Hallum
06/17/20 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
06/17/20 Canaccord
Chembio Diagnostics downgraded to Hold at Canaccord
CEMI Chembio Diagnostics
$4.17 /

+0.89 (+27.13%)

  • 07
    May
CEMI Chembio Diagnostics
$4.17 /

+0.89 (+27.13%)

CEMI Chembio Diagnostics
$4.17 /

+0.89 (+27.13%)

Hot Stocks
Uber appoints Flex CEO Revathi Advaithi to board » 16:40
07/02/20
07/02
16:40
07/02/20
16:40
UBER

Uber

$30.66 /

+0.24 (+0.79%)

, FLEX

Flex

$9.96 /

-0.08 (-0.80%)

On July 1, the Board of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$30.66 /

+0.24 (+0.79%)

FLEX Flex
$9.96 /

-0.08 (-0.80%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

07/01/20 BTIG
Uber consensus likely aggressive, says BTIG
06/30/20 SunTrust
Uber shouldn't face regulatory issues if it buys Postmates, says Suntrust
06/25/20 Deutsche Bank
Yandex interest in Uber's minority stake modest positive, says Deutsche Bank
06/16/20 JPMorgan
JPMorgan continues to prefer Facebook, Snap in online advertising
FLEX Flex
$9.96 /

-0.08 (-0.80%)

04/22/20 RBC Capital
Flex initiated with a Sector Perform at RBC Capital
03/11/20 JPMorgan
JPMorgan downgrades TTM Technologies to Neutral, prefers others in space
03/10/20 Citi
Flex price target lowered to $13 from $16 at Citi
02/24/20 Stifel
Stifel expects Amphenol peers to follow company in warning due to coronavirus
UBER Uber
$30.66 /

+0.24 (+0.79%)

FLEX Flex
$9.96 /

-0.08 (-0.80%)

  • 11
    Feb
  • 07
    Nov
  • 06
    Nov
UBER Uber
$30.66 /

+0.24 (+0.79%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

Conference/Events
Semtech participates in a conference call with B. Riley FBR » 16:38
07/02/20
07/02
16:38
07/02/20
16:38
SMTC

Semtech

$52.54 /

+1.5 (+2.94%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMTC Semtech
$52.54 /

+1.5 (+2.94%)

SMTC Semtech
$52.54 /

+1.5 (+2.94%)

05/28/20 Needham
Semtech price target raised to $65 from $47 at Needham
05/28/20 Loop Capital
Semtech price target raised to $61 from $46 at Loop Capital
05/28/20 Wells Fargo
Semtech price target raised to $57 from $50 at Wells Fargo
05/28/20 Susquehanna
Semtech price target raised to $50 from $40 at Susquehanna
SMTC Semtech
$52.54 /

+1.5 (+2.94%)

SMTC Semtech
$52.54 /

+1.5 (+2.94%)

General news
Fed Balance Sheet Level data reported » 16:37
07/02/20
07/02
16:37
07/02/20
16:37

Week of 7/1 Fed Balance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Money Supply M2 Weekly Change data reported » 16:37
07/02/20
07/02
16:37
07/02/20
16:37

Week of 6/22 Money Supply…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Atreca files $300M mixed securities shelf  16:35
07/02/20
07/02
16:35
07/02/20
16:35
BCEL

Atreca

$22.70 /

+0.57 (+2.58%)

 
ShowHide Related Items >><<
BCEL Atreca
$22.70 /

+0.57 (+2.58%)

BCEL Atreca
$22.70 /

+0.57 (+2.58%)

07/01/20 Canaccord
Atreca price target raised to $33 from $23 at Canaccord
06/10/20 H.C. Wainwright
H.C. Wainwright says Genmab/AbbVie pact a 'big win' for companies like Atreca
04/22/20 H.C. Wainwright
Atreca initiated with a Buy at H.C. Wainwright
04/21/20 Wedbush
Atreca initiated with an Outperform at Wedbush
BCEL Atreca
$22.70 /

+0.57 (+2.58%)

Hot Stocks
ReTo Eco-Solutions receives noncompliance notice from Nasdaq » 16:34
07/02/20
07/02
16:34
07/02/20
16:34
RETO

ReTo Eco-Solutions

$1.26 /

+0.03 (+2.44%)

ReTo Eco-Solutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RETO ReTo Eco-Solutions
$1.26 /

+0.03 (+2.44%)

Hot Stocks
Regeneron falls 3.5% after ph.3 data on Kevzara in Covid patients  16:33
07/02/20
07/02
16:33
07/02/20
16:33
REGN

Regeneron

$622.75 /

+13.53 (+2.22%)

 
ShowHide Related Items >><<
REGN Regeneron
$622.75 /

+13.53 (+2.22%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
REGN Regeneron
$622.75 /

+13.53 (+2.22%)

  • 27
    May
REGN Regeneron
$622.75 /

+13.53 (+2.22%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

On The Fly
Fly Intel: Wall Street's top stories for Thursday » 16:32
07/02/20
07/02
16:32
07/02/20
16:32
TSLA

Tesla

$1,208.00 /

+88.84 (+7.94%)

, F

Ford

$6.05 /

+0.065 (+1.09%)

, MCD

McDonald's

$183.55 /

-0.95 (-0.51%)

, LMND

Lemonade

$69.38 /

+ (+0.00%)

, MRNA

Moderna

$58.57 /

-3.06 (-4.97%)

, GRAF

Graf Industrial

$20.56 /

+6.605 (+47.33%)

, NUS

Nu Skin

$48.09 /

+9.605 (+24.96%)

, MEIP

MEI Pharma

$3.48 /

-0.79 (-18.50%)

, MTCH

Match Group

$98.89 /

-7.35 (-6.92%)

Stocks closed out the…

Open Full Text

ShowHide Related Items >><<
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

F Ford
$6.05 /

+0.065 (+1.09%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

GRAF Graf Industrial
$20.56 /

+6.605 (+47.33%)

NUS Nu Skin
$48.09 /

+9.605 (+24.96%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

08:00 Today Wedbush
Wedbush boosts Tesla target to $1,250 with new bull case of $2,000
07/01/20 Wedbush
'Impressive' trajectory in June bodes well for Tesla deliveries, says Wedbush
06/30/20 Oppenheimer
Oppenheimer anticipates in-line or ahead of consensus Q2 deliveries for Tesla
06/30/20 JMP Securities
Tesla price target raised to $1,050 from $1,001 at JMP Securities
F Ford
$6.05 /

+0.065 (+1.09%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
Ford price target raised to $7 from $6 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
MCD McDonald's
$183.55 /

-0.95 (-0.51%)

06/24/20 BMO Capital
McDonald's price target raised to $220 from $215 at BMO Capital
06/24/20 JPMorgan
McDonald's price target raised to $204 from $180 at JPMorgan
06/17/20 Morgan Stanley
McDonald's price target raised to $200 from $189 at Morgan Stanley
06/17/20 SunTrust
McDonald's price target raised to $208 from $195 at SunTrust
LMND Lemonade
$69.38 /

+ (+0.00%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

09:18 Today BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/26/20 Morgan Stanley
Morgan Stanley says Axios overstates contention on Moderna-NIH vaccine ownership
GRAF Graf Industrial
$20.56 /

+6.605 (+47.33%)

NUS Nu Skin
$48.09 /

+9.605 (+24.96%)

10:09 Today
Fly Intel: Top five analyst upgrades
07:52 Today DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07:12 Today DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
06:20 Today Jefferies
Jefferies upgrades Nu Skin to Buy, sees 15%-20% share upside
MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

05/29/20
Fly Intel: Top five analyst initiations
05/29/20 SunTrust
MEI Pharma initiated with a Buy at SunTrust
04/14/20 JonesTrading
MEI Pharma price target raised to $9 from $6 at JonesTrading
04/14/20 Wells Fargo
MEI Pharma price target raised to $13 from $11 at Wells Fargo
MTCH Match Group
$98.89 /

-7.35 (-6.92%)

06:24 Today BTIG
IAC price target lowered to $150 from $330 at BTIG
06/23/20 SunTrust
SunTrust raises price targets on IAC, Angi Homeservices, Match Group
06/23/20 BMO Capital
Angi Homeservices price target raised to $16 from $10 at BMO Capital
06/23/20 BMO Capital
IAC price target raised to $369 from $316 at BMO Capital
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

F Ford
$6.05 /

+0.065 (+1.09%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

NUS Nu Skin
$48.09 /

+9.605 (+24.96%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

  • 02
    Jul
  • 19
    May
  • 14
    Feb
  • 12
    Feb
  • 17
    Dec
TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

F Ford
$6.05 /

+0.065 (+1.09%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

GRAF Graf Industrial
$20.56 /

+6.605 (+47.33%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

F Ford
$6.05 /

+0.065 (+1.09%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

LMND Lemonade
$69.38 /

+ (+0.00%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

NUS Nu Skin
$48.09 /

+9.605 (+24.96%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

F Ford
$6.05 /

+0.065 (+1.09%)

MCD McDonald's
$183.55 /

-0.95 (-0.51%)

MRNA Moderna
$58.57 /

-3.06 (-4.97%)

MEIP MEI Pharma
$3.48 /

-0.79 (-18.50%)

MTCH Match Group
$98.89 /

-7.35 (-6.92%)

TSLA Tesla
$1,208.00 /

+88.84 (+7.94%)

Hot Stocks
Regeneron/Sanofi's ph3 trial of Kevzara in COVID did not meet endpoints » 16:32
07/02/20
07/02
16:32
07/02/20
16:32
SNY

Sanofi

$51.65 /

+0.37 (+0.72%)

, REGN

Regeneron

$622.75 /

+13.53 (+2.22%)

Regeneron (REGN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$51.65 /

+0.37 (+0.72%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

SNY Sanofi
$51.65 /

+0.37 (+0.72%)

07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
06/24/20 Roth Capital
Translate Bio price target raised to $30 from $25 at Roth Capital
06/23/20 Jefferies
Translate Bio price target raised to $29 from $17 at Jefferies
REGN Regeneron
$622.75 /

+13.53 (+2.22%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
SNY Sanofi
$51.65 /

+0.37 (+0.72%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

  • 27
    May
SNY Sanofi
$51.65 /

+0.37 (+0.72%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

SNY Sanofi
$51.65 /

+0.37 (+0.72%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

SNY Sanofi
$51.65 /

+0.37 (+0.72%)

REGN Regeneron
$622.75 /

+13.53 (+2.22%)

Syndicate
Personalis files to sell 11.53M shares of common stock for holders  16:31
07/02/20
07/02
16:31
07/02/20
16:31
PSNL

Personalis

$14.24 /

+0.51 (+3.71%)

 
ShowHide Related Items >><<
PSNL Personalis
$14.24 /

+0.51 (+3.71%)

PSNL Personalis
$14.24 /

+0.51 (+3.71%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA/Merrill
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA/Merrill
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$14.24 /

+0.51 (+3.71%)

PSNL Personalis
$14.24 /

+0.51 (+3.71%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.